scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1590-8658(00)80266-2 |
P698 | PubMed publication ID | 11030191 |
P50 | author | Dimitrios P. Bogdanos | Q48362185 |
P2093 | author name string | Mieli-Vergani G | |
Vergani D | |||
P2860 | cites work | NOSA in HCV infection: markers or makers of disease? | Q43086841 |
Type II autoimmune hepatitis. What is the role of the hepatitis C virus? | Q43754284 | ||
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity | Q44765063 | ||
Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. | Q45768672 | ||
Non-organ specific autoantibodies associated with chronic C virus hepatitis. | Q45777834 | ||
Antigenic mimicry between measles virus and human T lymphocytes | Q45831201 | ||
Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. | Q52847990 | ||
The geographic distribution of multiple sclerosis: a review. | Q54252998 | ||
Anti-HCV, anti-GOR, and autoimmunity | Q58803527 | ||
Molecular mimicry and autoimmune disease | Q69205630 | ||
A population-based study of multiple sclerosis in twins | Q69671085 | ||
Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America | Q71563583 | ||
Immunological liver diseases in children | Q77415695 | ||
Epidemiologic evidence for multiple sclerosis as an infection | Q24615844 | ||
Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein | Q27473443 | ||
Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6 | Q27473554 | ||
Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort | Q27477841 | ||
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection | Q27480424 | ||
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition | Q27485138 | ||
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues | Q27486795 | ||
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
Molecular mimicry between non-self, modified self and self in autoimmunity | Q28266657 | ||
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. | Q30846833 | ||
Discordance for ankylosing spondylitis in monozygotic twins | Q33570100 | ||
Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. | Q33720363 | ||
Molecular mimicry and autoimmunity. | Q33806107 | ||
Hepatitis B infection: pathogenesis and management | Q33870241 | ||
LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein | Q34293468 | ||
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile | Q34439843 | ||
Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone | Q36377205 | ||
Cytotoxic T cells and viral hepatitis | Q37365416 | ||
Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes | Q37371756 | ||
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis | Q37388003 | ||
Rubella infection and diabetes mellitus | Q39471844 | ||
The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology | Q40292992 | ||
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction | Q40443039 | ||
Side effects of alpha interferon in chronic hepatitis C. | Q40646343 | ||
Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection | Q40649145 | ||
Molecular mimicry: can epitope mimicry induce autoimmune disease? | Q40653042 | ||
Review of the contribution of twin studies in the search for non-genetic causes of multiple sclerosis | Q41028264 | ||
Molecular mimicry in the MHC: hidden clues to autoimmunity? | Q41113067 | ||
Virus-induced autoimmune disease | Q41312501 | ||
Molecular mimicry and T cell-mediated autoimmune disease | Q41470763 | ||
Non-organ specific autoantibodies in children with chronic hepatitis C. | Q42980425 | ||
Anti-GOR and hepatitis C virus in autoimmune liver diseases | Q42982616 | ||
An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen | Q42985987 | ||
Hepatitis C virus and autoimmunity | Q42999073 | ||
Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis | Q43048302 | ||
LKM antibody: getting in some target practice | Q43086504 | ||
P433 | issue | 5 | |
P304 | page(s) | 440-446 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Digestive and Liver Disease | Q15766194 |
P1476 | title | Virus, liver and autoimmunity | |
P478 | volume | 32 |